查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1808403

动物感染疾病诊断市场（依疾病类别、产品、动物类型和最终用途）－2025-2030 年全球预测

Veterinary Infectious Disease Diagnostics Market by Disease Category, Product, Offering, Animal Type, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计动物感染疾病诊断市场规模到 2024 年将达到 22.4 亿美元，到 2025 年将达到 24.2 亿美元，到 2030 年将达到 36.3 亿美元，复合年增长率为 8.37%。

主要市场统计数据
基准年2024年 22.4亿美元
预计2025年 24.2亿美元
预计2030年 36.3亿美元
复合年增长率（%） 8.37%

为兽医感染疾病诊断的突破性进展及其对动物健康管理的影响奠定基础

兽医感染疾病诊断技术的进步正在重塑临床医生和研究人员的动物健康管理方式。尖端分子技术、快速就地检验和数据驱动的决策支援工具的融合，使得伴侣动物和生产动物的致病威胁能够更早发现并更准确地识别。因此，兽医专业人员现在能够主动干预，降低发病率和死亡率，同时最大限度地降低通用感染疾病的传播风险。

揭开重新定义兽医感染疾病诊断领域并推动整个动物健康领域临床创新的革命性变化

在兽医诊断领域，几个关键趋势正在汇聚，重新定义感染疾病检测和监测的范式。其中最主要的是从单一分析物检测到多重和综合组合检测的转变。透过同时检测多种病原体，这些进步缩短了诊断时间，并提供更全面的临床资讯。分析硬体的微型化进一步放大了这项变革，支援在现场环境和远端诊所部署携带式设备。

2025年美国新关税对动物感染疾病诊断供应供应链和创新影响的全面评估

美国将于2025年对进口兽医诊断产品加征关税，将为全球供应链带来新的复杂性。试剂、检测套组和分析仪组件的供应商正面临成本上涨，这些成本已开始渗透到定价结构中。这些成本的增加迫使製造商和最终用户重新评估筹资策略和库存管理通讯协定。

揭示全面的细分洞察，重点介绍各种动物感染疾病诊断类别和产品的关键驱动因素和成长模式

可以从几个关键角度审视动物感染疾病诊断市场，以揭示独特的驱动因素和新的商机。鑑于病原体的多样性，钩端螺旋体病和布氏桿菌症等细菌感染疾病需要快速的确认检测，而细小病毒和犬瘟热等病毒感染疾病则受益于高通量分子检测。细小病毒和犬瘟热等病毒威胁受益于高通量分子检测。真菌病原体虽然不太常见，但需要专门的培养和血清学检测平台，而寄生虫感染则需要高灵敏度的免疫检测来检测循环抗原。

分析影响全球主要市场中成熟经济体和新兴经济体动物感染疾病诊断未来的地理模式和区域动态

兽医感染疾病诊断的区域动态受动物所有权模式、农业实践和法律规范差异的影响。在美洲，美国和加拿大凭藉其强大的研究基础设施和成熟的兽医网络，在技术应用方面处于领先地位。随着畜牧业产量的扩大和伴侣动物照护的日益复杂化，拉丁美洲市场正在迅速发展，推动了对经济高效的诊断解决方案的需求。

介绍推动动物感染疾病诊断突破和增强市场竞争力的关键创新者和策略伙伴关係

少数几家主要企业正推动动物感染疾病诊断领域的创新，这些公司将卓越的研究成果与策略联盟结合。市场领导者致力于开发全面的分子诊断平台，以实现具有高分析灵敏度的多重病原体检测。这些平台与专为现场应用设计的试剂组相辅相成，使实验室诊断能力能够无缝迁移到农场和诊所环境。

实施以相关人员为目标的策略和营运框架，以加速兽医诊断领域的发展并克服挑战

寻求抓住新商机的产业领导者应优先投资能够实现多重病原体检测的下一代分子平台。扩大内部研发能力或与专业生技公司合作，可加速产品上市时间，并确保产品符合临床需求。此外，透过多元化筹资策略和在地化生产增强供应链韧性，可以降低关税和物流风险。

严谨的调查方法结合定量分析和专家检验，为兽医感染疾病诊断提供了可靠的见解

本报告的研究结果基于严谨的调查方法，融合了定量分析和专家检验。市场洞察基于二手资料研究，利用同行评审期刊、公共卫生资料库、监管文件和技术白皮书。全面的文献综述提供了对新兴趋势和技术突破的透彻理解。

摘要关键见解和策略重点，为不断发展的动物感染疾病诊断生态系统的决策提供参考

摘要：由于技术创新、法规演变和贸易政策变化，动物感染疾病诊断市场正经历重大变革时期。多重分子检测、照护现场设备和数据分析平台的兴起正在重新定义诊断工作流程，并使伴侣动物和牲畜的疾病管理更加积极主动。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 开发用于同时检测伴侣动物中通用感染疾病的多重PCR检测板
  • 扩大基于 CRISPR 的诊断方法，实现快速、现场可部署的兽医病原体鑑定
  • 整合人工智慧影像分析工具，在牲畜健康检查中及早发现感染疾病标记物
  • 用于现场筛检牲畜抗生素抗药性的可携式微流体生物感测器装置的开发
  • 利用次世代定序全面监测新兴病毒和细菌病原体
  • 实施具有远距离诊断测试的远端医疗平台，以改善农村地区获得兽医护理的机会
  • 兽医诊断测试的标准化和监管协调，以简化全球市场核准
  • 侧流免疫检测技术在禽类养殖中用于经济有效的地方病常规监测的进展
  • 利用数位资料分析平台将诊断结果与农场管理系统结合，以获得即时洞察
  • 宠物医疗成本的上涨和健康趋势的上升正在推动伴侣动物感染疾病诊断的扩大

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章：动物感染疾病诊断市场（依疾病类别）

  • 细菌
  • 真菌
  • 寄生虫
  • 病毒性的

第九章动物感染疾病诊断市场（依产品）

  • 耗材
    • 试剂
    • 检测套组
  • 仪器/分析仪
    • 临床化学分析仪
    • 血液分析仪
    • 免疫诊断分析仪
    • 分子诊断分析仪

第 10 章动物感染疾病诊断市场（依产品提供）

  • 硬体
  • 服务
  • 软体

第11章动物感染疾病诊断市场（依动物类型）

  • 伴侣动物
    • 猫
    • 狗
  • 牲畜/生产动物
    • 牛
    • 山羊
    • 家禽
    • 羊
    • 猪

第 12 章：动物感染疾病诊断市场（依最终用途）

  • 内部测试设施
    • 动物收容所
    • 宠物饲主
  • 实验室
  • 兽医医院和诊所

13.美洲动物感染疾病诊断市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14.欧洲、中东和非洲动物感染疾病诊断市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15. 亚太动物感染疾病诊断市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Agrolabo SpA
    • Antech Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • Biogal Galed Labs
    • BioMerieux SA
    • BioNote, Inc.
    • Demeditec Diagnostics GmbH
    • DEXX Laboratories Inc.
    • Eurofins Technologies
    • Fassisi GmbH
    • FUJIFILM Holdings Corporation
    • IDvet
    • Mars, Incorporated
    • Merck & Co., Inc.
    • Neogen Corporation
    • Nisseiken Co., Ltd
    • Qiagen NV
    • Randox Laboratories, Ltd.
    • Shenzhen Bioeasy Biotechnology Co., Ltd.
    • Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • SKYER, Inc.
    • Skyla Corporation
    • Thermo Fisher Scientific Inc.
    • Vimian Group AB
    • Virbac SA

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第20章 研究报导

第21章 附录

Product Code: MRR-742BD5184F0A

The Veterinary Infectious Disease Diagnostics Market was valued at USD 2.24 billion in 2024 and is projected to grow to USD 2.42 billion in 2025, with a CAGR of 8.37%, reaching USD 3.63 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.24 billion
Estimated Year [2025] USD 2.42 billion
Forecast Year [2030] USD 3.63 billion
CAGR (%) 8.37%

Setting the Stage for Transformative Advances in Veterinary Infectious Disease Diagnostics and Their Impact on Animal Health Management

Advances in veterinary infectious disease diagnostics are reshaping the way clinicians and researchers approach animal health management. The convergence of cutting-edge molecular techniques, rapid point-of-care testing, and data-driven decision support tools enables earlier detection and more accurate identification of pathogenic threats across both companion and production species. Consequently, veterinary professionals are now equipped with the capacity to intervene proactively, reducing morbidity and mortality while also minimizing the risk of zoonotic transmission.

Over the past decade, growing awareness of One Health principles has intensified collaboration between animal and human health sectors. This synergy not only fosters shared learning but also drives investment in diagnostic innovation that benefits both fields. As a result, novel platforms have emerged that integrate multiplex assay functionality with digital connectivity, allowing real-time monitoring and seamless data exchange. In turn, these developments support epidemiological surveillance programs and targeted treatment protocols.

Moreover, regulatory frameworks are evolving in response to the accelerated pace of technological advancement. Harmonization efforts among global agencies aim to streamline approval processes for novel diagnostic reagents and platforms while ensuring robust validation standards. In parallel, supply chain resilience is becoming an imperative as stakeholders confront disruptions related to geopolitical tensions, trade policies, and logistic constraints. By anticipating these challenges and embracing adaptive strategies, practitioners and industry leaders can sustain innovation pipelines and deliver solutions that address the most pressing infectious disease threats in veterinary medicine.

Uncovering the Revolutionary Shifts Redefining the Veterinary Infectious Disease Diagnostics Landscape and Driving Clinical Innovation Across Animal Health Sectors

Across the veterinary diagnostics sector, several pivotal trends are converging to redefine the infection detection and monitoring paradigm. Foremost among these is the transition from single-analyte assays toward multiplex and syndromic panels. By enabling simultaneous detection of multiple pathogens, these advancements reduce time to diagnosis and provide a more comprehensive clinical picture. This transformative shift is further amplified by the miniaturization of analytic hardware, which supports deployment of portable devices in field settings and remote clinics.

Equally significant is the rise of molecular isothermal amplification techniques, which offer robust sensitivity comparable to polymerase chain reaction without the need for complex thermal cycling. Coupled with smartphone integration and cloud-based data management, point-of-care diagnostics are becoming increasingly user-friendly and accessible. As a result, diagnostic workflows are transitioning from centralized laboratories to decentralized frameworks, empowering veterinarians to make rapid, evidence-based decisions at the site of care.

In parallel, the incorporation of advanced data analytics and machine learning is unlocking novel insights from diagnostic outputs. Algorithms trained on extensive historical datasets can now predict outbreak patterns, guide antimicrobial stewardship, and optimize herd health management. Furthermore, collaborations between diagnostic developers and academic institutions are accelerating the translation of cutting-edge biomarkers into practical assays. Together, these shifts signal a new era in which diagnostic innovation and digital transformation converge to enhance animal welfare, protect public health, and drive economic value across the veterinary ecosystem.

Transitioning from traditional workflows, the procurement and supply chain models are adapting to support just-in-time delivery of critical reagents and consumables. Manufacturers are exploring localized distribution centers and additive manufacturing techniques to reduce lead times and mitigate logistics risks. Alongside these operational changes, regulatory agencies are updating guidelines to accommodate novel diagnostic modalities and digital health integrations. The combined effect of these shifts is a more responsive, resilient landscape that can adapt to emergent disease challenges with greater agility.

Evaluating the Comprehensive Effects of Newly Implemented United States Tariffs in 2025 on the Veterinary Infectious Disease Diagnostics Supply Chain and Innovation

The implementation of United States tariffs on veterinary diagnostic imports in 2025 has introduced a new layer of complexity to the global supply chain. Suppliers of reagents, test kits, and analyzer components are facing elevated costs that have begun to ripple through pricing structures. These added expenses place pressure on both manufacturers and end-use facilities to reevaluate procurement strategies and inventory management protocols.

In response to higher duty rates, several stakeholders are pursuing alternative sourcing avenues. Regional distribution networks are expanding their footprint to mitigate reliance on tariff-affected imports. At the same time, domestic producers are exploring strategic partnerships with component manufacturers to localize critical reagent production. This trend underscores the importance of a resilient supply ecosystem capable of withstanding regulatory and economic headwinds.

Moreover, increased input costs are incentivizing end users to optimize diagnostic workflows for cost efficiency. Veterinary hospitals and research laboratories are negotiating bundled service agreements and exploring reagent rental models to balance capital expenditure with operational flexibility. These adaptations reflect a broader shift toward collaborative purchasing and shared resource frameworks.

Looking ahead, industry participants anticipate that evolving trade policies will remain a defining factor in strategic decision-making. Companies that invest in agile manufacturing, robust supplier diversification, and proactive policy engagement will be best positioned to sustain growth. Ultimately, the capacity to navigate tariff dynamics will determine the long-term viability of new diagnostic platforms and their adoption across various veterinary settings.

Unveiling Comprehensive Segmentation Insights Revealing Critical Drivers and Growth Patterns Across Diverse Veterinary Infectious Disease Diagnostic Categories and Products

The veterinary infectious disease diagnostics market can be examined through several critical lenses that reveal unique drivers and emerging opportunities. When considering pathogen diversity, bacterial infections such as leptospirosis and brucellosis demand rapid confirmatory testing, while viral threats like parvovirus and canine distemper benefit from high-throughput molecular assays. Fungal pathogens, although less prevalent, necessitate specialized culture and serology platforms, and parasitic infestations require sensitive immunoassays to detect circulating antigens.

Turning to product offerings, consumables represent a significant share of laboratory expenditure, particularly the reagents and test kits that support both traditional and molecular workflows. Instruments and analyzers span a wide spectrum from clinical chemistry devices and hematology counters to point-of-care immunodiagnostic readers and advanced molecular diagnostic platforms. Each category carries distinct cost-benefit considerations related to throughput, ease of use, and maintenance requirements.

Within the framework of solution delivery, hardware investments in next-generation sequencers and multiplex analyzers are complemented by software solutions that enable data analytics and remote monitoring. Service agreements, including preventive maintenance and technical support, serve as a backbone for instrument uptime and operator proficiency, creating recurring revenue streams that underpin long-term vendor relationships.

Animal type segmentation further refines market focus. Companion animals such as cats and dogs benefit from rapid in-clinic assays that drive pet owner satisfaction, while livestock testing protocols for cattle, swine, and poultry emphasize herd-level health and productivity metrics. End users vary from in-house testing facilities at research institutions and shelters to dedicated veterinary hospitals and clinics. Each segment exhibits distinct adoption curves governed by budgetary constraints, throughput expectations, and regulatory compliance requirements.

Analyzing Geographical Patterns and Regional Dynamics Shaping the Future of Veterinary Infectious Disease Diagnostics across Established and Emerging Economies in Key Global Markets

Regional dynamics in veterinary infectious disease diagnostics are shaped by variations in animal ownership patterns, agricultural practices, and regulatory frameworks. In the Americas, the United States and Canada lead in technological adoption, leveraging strong research infrastructures and well-established veterinary networks. Markets in Latin America are emerging rapidly as livestock production expands and companion animal care becomes more sophisticated, driving demand for cost-effective diagnostic solutions.

Europe, Middle East & Africa present a diverse landscape. Western European countries benefit from harmonized regulations under the European Medicines Agency, facilitating cross-border distribution of advanced diagnostic kits and analyzers. In contrast, markets in the Middle East and Africa are characterized by fragmented regulatory environments and infrastructural constraints, which create opportunities for portable, robust testing platforms and capacity-building partnerships.

The Asia-Pacific region is distinguished by its high livestock density and growing companion animal segment in countries such as China, India, and Australia. Government initiatives promoting animal health and food safety have spurred investments in large-scale diagnostic laboratories. Meanwhile, smaller clinics are adopting point-of-care tests to meet increasing demand for rapid turnarounds, particularly in remote and rural geographies.

Across all regions, emerging economies are prioritizing investments in local production capabilities to reduce dependency on imports and improve cost resilience. Data sharing agreements and collaborative surveillance programs are on the rise, fostering a more integrated global ecosystem for disease monitoring and outbreak preparedness.

Profiling Leading Innovators and Strategic Partnerships Driving Breakthroughs in Veterinary Infectious Disease Diagnostics and Enhancing Market Competitiveness

Innovation in veterinary infectious disease diagnostics is propelled by a handful of leading companies that combine research excellence with strategic alliances. One category of market leaders has focused on developing comprehensive molecular diagnostic platforms that deliver multiplex pathogen detection with high analytical sensitivity. These platforms are complemented by reagent kits designed for field use, enabling seamless translation of laboratory capabilities into on-farm and in-clinic settings.

Another cohort of innovators has prioritized digital integration. By embedding connectivity features into analyzers and employing cloud-based data management, these firms offer real-time result sharing and remote monitoring services. Such capabilities support centralized oversight of multi-site operations, facilitating consistent quality standards and streamlined troubleshooting.

Strategic partnerships between diagnostic developers and academic or governmental research institutes have accelerated the validation of novel biomarkers and the launch of next-generation tests. Collaborative consortia that focus on zoonotic disease surveillance bring together cross-sector stakeholders to co-create solutions that address unmet needs. In parallel, service-oriented business models-featuring comprehensive maintenance agreements and user-training programs-have become critical differentiators that promote long-term customer loyalty.

Looking ahead, agile market entrants are expected to leverage modular platform designs, customizable workflows, and subscription-based software licensing to enhance flexibility and reduce total cost of ownership. These strategies reflect an industry-wide emphasis on delivering end-to-end solutions that align with the evolving demands of veterinary practitioners and research laboratories alike.

Implementing Targeted Strategies and Operational Frameworks for Industry Stakeholders to Accelerate Growth and Navigate Challenges in Veterinary Diagnostics

Industry leaders seeking to capitalize on emerging opportunities should prioritize investments in next-generation molecular platforms capable of multiplex pathogen detection. By expanding internal R&D capabilities or forging alliances with specialized biotechnology firms, they can accelerate time to market and ensure alignment with clinical needs. In addition, strengthening supply chain resilience through diversified sourcing strategies and localized manufacturing will mitigate tariff and logistics risks.

Digital transformation should be advanced through the integration of software solutions that enable remote monitoring, data analytics, and predictive modeling. Piloting these technologies in select sites will provide valuable user feedback and inform scalable deployment plans. Concurrently, engagement with regulatory authorities and participation in harmonization initiatives will streamline approval pathways for novel diagnostics and foster a more predictable innovation landscape.

Cross-sector collaboration represents another critical success factor. By partnering with academic laboratories, public health agencies, and agricultural stakeholders, organizations can access unique datasets and validate emerging biomarkers under real-world conditions. Establishing formal consortia for zoonotic disease surveillance also enhances market credibility and opens new channels for funding and co-development.

Finally, workforce development must be addressed through targeted training programs that elevate operator proficiency and technical expertise. Investing in customer education-via workshops, online modules, and certification tracks-reinforces product value propositions and drives sustained market engagement.

Outlining Rigorous Research Methodology Combining Quantitative Analysis and Expert Validation to Ensure Robust Insights into Veterinary Infectious Disease Diagnostics

This report's findings are grounded in a rigorous research methodology that integrates both quantitative analysis and expert validation. Secondary research formed the foundation of market understanding, drawing on peer-reviewed journals, public health databases, regulatory filings, and technical white papers. This comprehensive literature review ensured that emerging trends and technological breakthroughs were thoroughly captured.

Primary research was conducted through in-depth interviews with key opinion leaders, including veterinary practitioners, laboratory directors, academic researchers, and industry executives. These conversations provided real-world perspectives on diagnostic adoption drivers, workflow inefficiencies, and unmet clinical needs. In addition, targeted surveys of end users were deployed to quantify adoption levels, budgetary constraints, and purchasing preferences across different segments.

Data triangulation techniques were applied to reconcile findings from multiple sources and enhance overall accuracy. Preliminary conclusions were subjected to a validation round with an advisory panel composed of subject matter experts, who provided critical feedback on assumptions and scenario analyses. This iterative review cycle helped refine market segmentation frameworks and ensure robustness of regional and regulatory insights.

Quality control measures, including cross-dataset consistency checks and hypothesis testing, were implemented throughout the research process. The result is a set of actionable insights and strategic recommendations that reflect both empirical data and frontline expertise, empowering decision-makers to navigate the dynamic landscape of veterinary infectious disease diagnostics with confidence.

Summarizing Key Insights and Strategic Imperatives to Inform Decision Making in the Evolving Veterinary Diagnostics Ecosystem for Infectious Diseases

In summary, the veterinary infectious disease diagnostics market is undergoing a period of profound transformation driven by technological innovation, regulatory evolution, and shifting trade policies. The rise of multiplex molecular assays, point-of-care devices, and data analytics platforms is redefining diagnostic workflows and enabling more proactive disease management across both companion and production animals.

Tariff adjustments in 2025 have underscored the necessity of supply chain resilience and strategic procurement models. Organizations that invest in localized manufacturing, supplier diversification, and collaborative purchasing arrangements will be best prepared to navigate cost pressures and maintain service continuity. Meanwhile, segmentation analysis highlights distinct adoption patterns across disease categories, product typologies, and end-use settings, guiding targeted go-to-market strategies.

Regional dynamics further illustrate the importance of aligning product portfolios with local infrastructure, regulatory requirements, and customer needs. From the technologically advanced markets of North America and Western Europe to the fast-growing economies of Asia-Pacific and Latin America, opportunities abound for agile companies that tailor solutions effectively.

Ultimately, success in this evolving ecosystem will hinge on integrated strategies that combine innovation in hardware, software, and services with strong stakeholder partnerships and robust market intelligence. Decision-makers who leverage these insights and proactively implement recommended actions will secure a leadership position in the next chapter of veterinary diagnostics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Development of multiplex PCR panels for simultaneous detection of zoonotic agents in companion animals
  • 5.2. Expansion of CRISPR-based diagnostics for rapid and field-deployable veterinary pathogen identification
  • 5.3. Integration of AI-driven image analysis tools to detect early infectious disease markers in livestock health screening
  • 5.4. Growth of portable microfluidic biosensor devices for on-site screening of antimicrobial resistance in farm animals
  • 5.5. Adoption of next-generation sequencing for comprehensive surveillance of emerging viral and bacterial pathogens
  • 5.6. Implementation of telemedicine platforms with remote diagnostic testing for improved veterinary care accessibility in rural areas
  • 5.7. Standardization and regulatory harmonization of veterinary diagnostic assays to streamline global market approvals
  • 5.8. Advancement of lateral flow immunoassays for cost-effective routine monitoring of endemic diseases in poultry operations
  • 5.9. Utilization of digital data analytics platforms to integrate diagnostic results with farm management systems for real-time insights
  • 5.10. Expansion of companion animal infectious disease diagnostics driven by increasing pet healthcare expenditure and wellness trends

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Veterinary Infectious Disease Diagnostics Market, by Disease Category

  • 8.1. Introduction
  • 8.2. Bacterial
  • 8.3. Fungal
  • 8.4. Parasitic
  • 8.5. Viral

9. Veterinary Infectious Disease Diagnostics Market, by Product

  • 9.1. Introduction
  • 9.2. Consumables
    • 9.2.1. Reagents
    • 9.2.2. Test kits
  • 9.3. Instruments/Analyzers
    • 9.3.1. Clinical chemistry analyzers
    • 9.3.2. Hematology analyzers
    • 9.3.3. Immunodiagnostic analyzers
    • 9.3.4. Molecular diagnostic analyzers

10. Veterinary Infectious Disease Diagnostics Market, by Offering

  • 10.1. Introduction
  • 10.2. Hardware
  • 10.3. Services
  • 10.4. Software

11. Veterinary Infectious Disease Diagnostics Market, by Animal Type

  • 11.1. Introduction
  • 11.2. Companion Animals
    • 11.2.1. Cat
    • 11.2.2. Dog
  • 11.3. Livestock/Production Animals
    • 11.3.1. Cattle
    • 11.3.2. Goats
    • 11.3.3. Poultry
    • 11.3.4. Sheep
    • 11.3.5. Swine

12. Veterinary Infectious Disease Diagnostics Market, by End Use

  • 12.1. Introduction
  • 12.2. In-House Testing Facilities
    • 12.2.1. Animal Shelters
    • 12.2.2. Pet Owners
  • 12.3. Research Laboratories
  • 12.4. Veterinary Hospitals & Clinics

13. Americas Veterinary Infectious Disease Diagnostics Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Veterinary Infectious Disease Diagnostics Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Veterinary Infectious Disease Diagnostics Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. IDEXX Laboratories, Inc.
    • 16.3.2. Zoetis Inc.
    • 16.3.3. Agrolabo S.p.A.
    • 16.3.4. Antech Diagnostics, Inc.
    • 16.3.5. Bio-Rad Laboratories, Inc.
    • 16.3.6. Biogal Galed Labs
    • 16.3.7. BioMerieux S.A.
    • 16.3.8. BioNote, Inc.
    • 16.3.9. Demeditec Diagnostics GmbH
    • 16.3.10. DEXX Laboratories Inc.
    • 16.3.11. Eurofins Technologies
    • 16.3.12. Fassisi GmbH
    • 16.3.13. FUJIFILM Holdings Corporation
    • 16.3.14. IDvet
    • 16.3.15. Mars, Incorporated
    • 16.3.16. Merck & Co., Inc.
    • 16.3.17. Neogen Corporation
    • 16.3.18. Nisseiken Co., Ltd
    • 16.3.19. Qiagen N.V.
    • 16.3.20. Randox Laboratories, Ltd.
    • 16.3.21. Shenzhen Bioeasy Biotechnology Co., Ltd.
    • 16.3.22. Shenzhen Mindray Animal Medical Technology Co., Ltd.
    • 16.3.23. SKYER, Inc.
    • 16.3.24. Skyla Corporation
    • 16.3.25. Thermo Fisher Scientific Inc.
    • 16.3.26. Vimian Group AB
    • 16.3.27. Virbac S.A.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCHAI
  • FIGURE 26. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCHCONTACTS
  • FIGURE 28. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTIC ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CAT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DOG, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL SHELTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PET OWNERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 123. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 124. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 125. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 126. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 127. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 128. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 137. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 138. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 139. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 140. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 141. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 143. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 144. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 145. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 146. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 147. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 148. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 149. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 150. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 153. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 154. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 155. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 156. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 157. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 158. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 159. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 160. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 161. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 163. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 164. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 165. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 166. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 167. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 168. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 171. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 172. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 173. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 174. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 175. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 176. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 177. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 178. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 179. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 180. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 181. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 183. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 184. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 185. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 186. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 191. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 192. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 193. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 194. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 195. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 196. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 197. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 198. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 199. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 200. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 201. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 204. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 240. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 242. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2025-2030 (USD MILLION)
  • TABLE 253. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 254. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025-2030 (USD MILLION)
  • TABLE 255. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 256. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 257. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 258. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
  • TABLE 259. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2024 (USD MILLION)
  • TABLE 260. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2025-2030 (USD MILLION)
  • TABLE 261. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
  • TABLE 262. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
  • TABLE 263. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 267. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2025-2030 (USD MILLION)
  • TABLE 269. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)

TA